Iktos is a start-up company specialized in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Their objective is to make their technology accessible to everyone, and to be the first company to release a user-friendly and high-performance de novo design software for multi-parameter optimization, that can be used by any medicinal or computational chemist, whatever their level of expertise in deep learning an...
- (25.May.2021) Iktos Announce Collaboration With UCB in AI for Retrosynthesis
- (18.May.2021) Iktos Announces Collaboration With Kadmon to Use AI for New Drug Design
- (11.May.2021) Iktos and Facio Therapies Announce Collaboration to Use AI for FSHD Drug Design
- (02.Mar.2021) Iktos Announces Collaboration With Pfizer in AI for Drug Design
- (05.Nov.2020) Iktos Announces Additional Collaboration With Merck KGaA, Darmstadt, Germany in AI for New Drug Design